Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions

Buttner C., Lun A., Splettstoesser T., Kunkel G., Renz H.

Source: Eur Respir J 2003; 21: 799-803
Journal Issue: May
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Buttner C., Lun A., Splettstoesser T., Kunkel G., Renz H.. Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions. Eur Respir J 2003; 21: 799-803

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Macrophages induce an allergen-specific and long-term suppression in a mouse asthma model
Source: Eur Respir J 2005; 26: 1040-1046
Year: 2005



IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide- but not allergen-induced airway neutrophilia
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002

Regulatory role of antigen-induced IL-10, produced by Tr1 cells, in airway neutrophilia in a murine model for asthma
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012


Allergen-specific immunotherapy results in increased IL-10 production of mononuclear cells and T-cell anergy
Source: Eur Respir J 2003; 22: Suppl. 45, 110s
Year: 2003

Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis
Source: Eur Respir J 2003; 21: 925-931
Year: 2003



Theophylline inhibits mobilization of eosinophil induced by interleukin-5 (IL-5) from femoral bone marrow into the blood
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005


A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α
Source: Eur Respir J 2003; 21: 387-393
Year: 2003



Up regulation of CD23 (FceRII) expression in human airway smooth muscle cells after exposure to IL-13
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005


LSC - 2019 - Anti-IL5 in mild asthma alters rhinovirus-induced macrophage, B cell and neutrophil responses
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019

Enhanced expression of IL-18 and increased CD8+ T cells and eosinophils in the airways of asthma death
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010


The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma
Source: Eur Respir J 2001; 18: 45-52
Year: 2001



IL-10 produced by CD4+ T cells is essential for the development of airway hyperresponsiveness via suppression of endogenous IL-12
Source: Eur Respir J 2005; 26: Suppl. 49, 24s
Year: 2005

Anti-IL-5 antibody reduces the increase of CD34+ eosinophils in a mouse model of airway allergic eosinophilia
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002

IL-15 transpresentation in circulating progenitors of NK cells controls their differentiation potential, STAT6 activation and IL-13 production
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005


Dendritic cell subsets in the lung: implication for allergic asthma
Source: Annual Congress 2006 - A new look at dendritic cell interactions in the lung
Year: 2006


Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011


New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5
Source: Eur Respir J 2001; 17: 499-506
Year: 2001



The effect of anti-IL-5 therapy on sputum cells and cytokines in asthmatics
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019


The PBMC of severe asthmatics showed enhanced candida antigen induced IL-5, IL-13 and TARC production and this enhancement was inhibited by dendric cells deprition
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009

Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006